Compare LQDA & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDA | PAGS |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2020 | 2017 |
| Metric | LQDA | PAGS |
|---|---|---|
| Price | $38.17 | $9.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $41.00 | $12.00 |
| AVG Volume (30 Days) | 933.3K | ★ 3.4M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | ★ 51.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $158,320,000.00 | N/A |
| Revenue This Year | $278.87 | $11.07 |
| Revenue Next Year | $57.13 | $7.26 |
| P/E Ratio | ★ N/A | $7.74 |
| Revenue Growth | ★ 1031.18 | N/A |
| 52 Week Low | $11.85 | $7.74 |
| 52 Week High | $46.67 | $12.32 |
| Indicator | LQDA | PAGS |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 41.66 |
| Support Level | $35.00 | $9.89 |
| Resistance Level | $39.19 | $10.26 |
| Average True Range (ATR) | 1.84 | 0.37 |
| MACD | -0.06 | -0.13 |
| Stochastic Oscillator | 38.71 | 8.05 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.